antineoplastic; a peptide that contains an HDM-2-binding domain from p53 attached to a membrane-penetrating peptide on its carboxyl terminal end, is cytotoxic to cancer, but not normal cells; amino acid sequence in first source
Source
Cancer Chemother Pharmacol. 2010 Jul;66(2):325-31)
